Phagelux, a leading anti-bacterial company based in Shanghai, announced the acquisition of the key assets of Scithera Microbial Technologies, headquartered in Wuhan China. The assets include intellectual property for multiple lysins and for the rapid development of lysin solutions. Phagelux also acquired Scithera’s scientific team who will be located in new Phagelux laboratory facilities at the BioLake Science Park in Wuhan.
Help employers find you! Check out all the jobs and post your resume.
